Abstract Aim: Increasing evidence demonstrates that circadian clock proteins are important regulators of physiological functions including blood pressure. An established risk factor for developing cardiovascular disease is the absence of a blood pressure dip during the inactive period. The goal of the present study was to determine the effects of a high salt diet plus mineralocorticoid on PER1-mediated blood pressure regulation in a salt-resistant, normotensive mouse model, C57BL/6J. Methods: Blood pressure was measured using radiotelemetry. After control diet, wild-type (WT) and Per1 (KO) knockout mice were given a high salt diet (4% NaCl) and the long-acting mineralocorticoid deoxycorticosterone pivalate. Blood pressure and activity rhythms were analysed to evaluate changes over time.
The circadian (Latin for 'around a day') clock functions to synchronize our daily activities, on a physiological and molecular level, with the time of day and certain behaviours that usually occur around the same time each day . Many physiological functions exhibit circadian rhythms, including blood pressure (BP). Healthy individuals experience a 10-20% decrease in BP at night. Individuals who do not exhibit this 'dip' in resting BP are termed 'nondippers'. Non-dipping is associated with an increased risk of chronic kidney disease (Kario & Shimada 2004 , Hermida et al. 2010 and adverse cardiovascular events (Ohkubo et al. 2002 , Liu et al. 2003 and can also be used to predict future cardiovascular events (Fagard et al. 2009 ). These risks are further increased by chronic hypertension, or high BP, which is also a risk factor for cardiovascular disease (CVD). CVD is the leading cause of death of Americans (Go et al. 2014) , accounting for nearly 1 million deaths/ year (Mozaffarian et al. 2015) . A subset of hypertensive patients exhibit salt-sensitive hypertension in which BP is abnormally elevated after high salt intake, implicating aberrant sodium handling in the pathogenesis of the disease. The underlying mechanisms of these pathologies remain incompletely understood.
At a basic level, the molecular clock is composed of four core genes which encode for BMAL1, CLOCK, CRYPTOCHROME (CRY, homologs 1 and 2) and PERIOD (PER, homologs 1, 2 and 3) proteins (for review of this complex mechanism (Partch et al. 2014) ). These four proteins form a transcriptiontranslation oscillating loop, with BMAL1 : CLOCK heterodimers positively regulating transcription of target genes and thus forming the positive arm of the loop. CRY : PER heterodimers make up the negative arm of the loop due to their antagonism of BMAL1 : CLOCK heterodimers bound at target gene E-box response elements and subsequent repression of transcription. A central clock located in the suprachiasmatic nucleus of the brain is entrained by light signals from the retina (Mills & Stanbury 1952) . These signals are then relayed through neuronal and humoral pathways to peripheral clocks located in other tissues and organs of the body.
The importance of circadian proteins for BP control is illustrated by knockout (KO) mice. Every clock gene KO mouse that has been tested exhibits a BP phenotype (Richards et al. 2014a) . Global Bmal1 KO mice lose circadian rhythmicity of BP and are hypotensive (Curtis et al. 2007) . Loss of Bmal1 in renin-producing cells in the kidney also leads to a significant decrease in BP compared to controls (Tokonami et al. 2014) . Loss of Clock causes mice to become hypotensive yet retain the circadian rhythm of BP (Zuber et al. 2009 ). Cry1/Cry2 global KO mice exhibit salt-sensitive hypertension (Saifur Rohman et al. 2005 , Doi et al. 2010 . Mice lacking all three Period isoforms lose their BP dip on a low salt diet (Pati et al. 2016) . Thus, the clock is a major regulator of baseline BP and rhythmic BP.
The kidney is a critical regulator of BP and many aspects of renal function oscillate in a circadian manner including sodium excretion, renal blood flow (Pons et al. 1996) and glomerular filtration rate (Koopman et al. 1989) . Aldosterone, a critical regulator of renal sodium handling, is also released in a circadian manner (Leliavski et al. 2015) . Gumz et al. identified Per1 as a novel aldosterone target gene in renal collecting ducts cells (Gumz et al. 2003 (Gumz et al. 2009 ). Subsequent studies provided further evidence that PER1 coordinately regulates several genes encoding proteins that function in renal sodium reabsorption (Richards et al. 2014b ,c, Solocinski et al. 2015 . Global loss of Per1 on the hypertensive, salt-sensitive 129/sv mouse strain resulted in significantly reduced BP compared to wild-type (WT) controls on a normal diet (Stow et al. 2012) .
The goal of the present study was to characterize the role of PER1 in the normotensive C57BL/6J background strain. Small but significant differences in mean arterial pressure (MAP) were observed between WT and PER1 KO mice at baseline. Since Per1 is an aldosterone target gene and coordinately regulates many renal sodium transport genes, we subjected WT and Per1 KO mice to a high salt (HS) diet in combination with desoxycorticosterone pivalate (DOCP) injection as a model for evaluating salt-sensitive changes in BP. DOCP is a long-acting aldosterone analog that bypasses the sodium-excreting effects of renin-angiotensin-aldosterone system (RAAS) suppression normally seen with high salt intake [reviewed in Atlas (2007) ] and leads to increased renal sodium reabsorption. Interestingly, loss of PER1 in C57BL/6 mice subjected to HS/DOCP treatment resulted in significantly elevated BP accompanied by disruption of the normal BP rhythm. Thus, PER1 appears to be an important regulator of baseline and rhythmic BP in C57BL/6J mice.
Methods

Mice
Male WT C57BL/6J mice and C57BL/6J Per1 KO between the ages of 14-18 weeks were used for these experiments (original heterozygous mice were the kind gift of Dr. Shin Yamazaki, Vanderbilt (Pendergast et al. 2009 ). WT and Per1 KO mice were litter mates derived from mating mice heterozygous for Per1. Mice were maintained on a normal 12-h : 12-h L : D cycle at the NF/SG VA Healthcare animal facility. Experiments were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals and with the approval of UF and VA Medical Center IACUCs. Mice were implanted with telemetry devices from Data Sciences International through the carotid artery and extended into the aortic arch following established protocol (Butz & Davisson 2001) and as described previously (Stow et al. 2012) . Mice were allowed at least 7 days to recover. Mice were then placed on control diet (0.2% NaCl; Harlan, Teklad (now Envigo), Madison, WI, USA) for at least 3 days, during which time baseline BP recordings were made. Mice were then placed on a high salt (4% NaCl; Harlan, Teklad (now Envigo)) diet for 3 more days, followed by injection with 75 lg g À1 bw DOCP. Three days after the injection and after six total days on a high salt diet, telemetry recordings for the HS/DOCP period were made.
Tissue dissection and real-time quantitative RT-PCR (qPCR)
Tissue dissection and qPCR were performed as described previously in Solocinski et al. (2015) .
Flame photometry
Flame photometry was used to determine urine and plasma Na and K concentrations.
Aldosterone ELISA
Plasma aldosterone was measured by ELISA as described in Richards et al. (2013a) .
Statistics
Day values are the 3-day averages of MAP between 6 am (ZT0) and 5 pm (ZT11). Night values are the 3-day averages of MAP recorded between 6 pm (ZT12) and 5 am (ZT23). Paired t-tests and standard and repeated measures two-way ANOVAs were performed as appropriate using GRAPHPAD PRISM software (version 6.07 for Windows, GraphPad Software, La Jolla, CA, USA, www.graphpad.com). Cosinor analysis was done using ClockLab software (Actimetrics) and the generous help of Dr. Joshua Speed (University of Alabama Birmingham). P < 0.05 was considered significant. JTK cycle was used as described (Wu et al. 2016) . The program cosinor was downloaded from www. Circadian.org (last accessed 09/01/2016). Values are shown as mean AE SEM.
Results
Given our previous findings that Per1 regulates a number of genes related to renal sodium reabsorption in vitro and in vivo in hypertensive 129/sv mice, we investigated the expression of candidate genes in WT normotensive C57BL/6 mice compared to Per1 KO mice. Real-time quantitative PCR (qPCR) was used to assess relative differences in gene expression in the renal cortex between WT and Per1 KO mice at two distinct time points in the circadian cycle. Kidneys were collected at noon and midnight in order to capture time points at the mid-point of the rest phase and the active phase respectively. We investigated timeand PER1-dependent changes in steady-state mRNA expression for genes known to contribute to renal sodium reabsorption or the regulation of this process. The angiotensin II receptor (AT 1 R) leads to increased sodium reabsorption and BP through the RAAS and has positive effects on ENaC (Crowley & Coffman 2012) and expression displays a significant change over time due to the interaction of time and genotype (P = 0.0075) (Fig. 1a) . UBE2E3, a ubiquitin E3 ligase, has been previously shown to regulate the alpha subunit of the epithelial sodium channel (aENaC) (Debonneville & Staub 2004) and is regulated by PER1 (Richards et al. 2014b) . As shown in Figure 1b , there was a significant effect of time on UBE2E3 expression (P = 0.015) with a trend towards a genotype effect as well (P = 0.065). Nitric oxide synthase 1 (NOS1) also regulates aENaC (Hyndman et al. 2015) (Fig. 1c ) and trended towards an interaction between genotype and time. With-no-lysine kinase 1 (WNK1) is a regulator of the sodium chloride cotransporter (Chavez-Canales et al. 2014) and trended towards a genotype-time interaction as well ( Fig. 1d ). Figure 1e shows that aENaC expression changed significantly with time (P = 0.024) and a possible trend for an interaction between time and genotype was observed (P = 0.12) (Fig. 1e) . In contrast to these changes, PCSK9, an ENaC-regulating protease, did not undergo any changes in expression relative to time or Per1 KO ( Figure S1a ). Likewise, mRNA levels for the endothelin A receptor, a regulator of renal sodium balance and blood pressure, did not change with time or Per1 KO ( Figure S1b ). Therefore, Per1 appears to selectively regulate only certain genes which govern sodium transport and reabsorption. Given our previous findings that PER1 acts as a coordinate regulator of several genes in the kidney that participate in the regulation of renal sodium reabsorption, we hypothesized that Per1 KO mice would exhibit altered BP. Due to the altered gene expression patterns observed in Figure 1 , we compared MAP between WT and KO mice under baseline conditions. The mice were implanted with telemetry devices and after recovery MAP was monitored over a 3-day period. During the day when mice are inactive, WTs have a MAP of 102.1 AE 1.7 mmHg which increases to 112.5 AE 1.08 mmHg during the night when they are active, an increase of 10.4 AE 1.5 mmHg (Fig. 2a) . Per1 KO mice exhibit an inactive phase MAP of 103 AE 1.4 mmHg which rises to 119.8 AE 0.9 during the active phase. This is a change of 16.8 AE 1.7 mmHg which is significantly higher than the inactive/active phase difference observed in WT mice (P < 0.05). In Figure 2b , hourly MAP data are shown. The 12-h period of the inactive phase is indicated by the white areas between zeitgeber time 0 (ZT0, 'lights on') and ZT12. The active phase is indicated by the shaded areas between ZT12 and ZT0. The dip in MAP during the inactive phase is easily visualized, as well as the slightly higher MAP in the Per1 KO mice seen during the dark/active period. Under these baseline conditions, significant differences between WT and Per1 KO mice in terms of plasma aldosterone levels, plasma Na or K, or body weight were not observed (Table 1) .
Given the subtle but significant differences in MAP between WT and Per1 KO mice under control conditions, we examined the response of both groups to an established model of salt sensitivity: high salt diet plus mineralocorticoid treatment. Following the baseline recordings presented in Figure 2 , the same mice were given a high salt diet (4% NaCl) in addition to injection of DOCP. Figure 3a shows day and night averages taken the same way as described in Figure 2 . WT mice exhibit a significant inactive/active phase difference in BP with an increase from 101.5 AE 1.92 mmHg during the inactive phase to 114.5 AE 1.1 mmHg during the active phase. This is a 13 AE 2.2 mmHg increase which is not different from the inactive/active difference in BP of WT mice observed under control conditions. In contrast, Per1 KO mice exhibited an inactive phase average MAP of 118.1 AE 1 mmHg that increased to 125.3 AE 1.5 mmHg during the active phase. This is a difference of only 7.2 AE 1.8 mmHg, which is significantly different from the WT and, importantly, classifies these mice as non-dippers. Panel B shows the hourly BP measurements, clearly illustrating the attenuated dip of the KO mice during the inactive phase.
In order to analyse the dipping pattern of the mice, we compared inactive/active phase differences in MAP of WT and Per1 KO mice under control and HS/ DOCP conditions (Fig. 4) . It is clear that Per1 KO mice have a greater decrease in MAP from the active to inactive phase compared to WT on control diet (Fig. 4a) . The Per1 KO dip of 14 AE 1.4% is significantly larger than the WT 9.2 AE 1.3% dip (P < 0.05) under baseline conditions. On HS/DOCP, WT mice maintain their dip in BP, whereas Per1 KO mice exhibit an attenuated inactive/active phase difference in BP (panel b). WT MAP decreases by 11.4 AE 1.9% from night to day while Per1 KO mice decrease only 5.7 AE 1.4% (P < 0.05). Diastolic and systolic BP changed in parallel with MAP ( Figure S2 ). In contrast to these differences in BP, inactive/active phase differences in activity patterns were higher in WT mice Telemetry recording of MAP with lights on from ZT0 to ZT12 depicted with light areas and ZT12 to ZT0, the time when lights are off, shaded grey. n = 8 for WT, n = 6 for Per1 KO. Significance was calculated by two-way ANOVA. **P < 0.001 compared to same genotype, w P < 0.05 compared to same time. Plasma concentrations of aldosterone, sodium (Na) and potassium (K) were determined from samples taken at noon and midnight from WT and Per1 KO mice. Significance was determined by two-way ANOVA (excluding body weight). Data are presented as mean AE SEM. *P < 0.05. n = 4 mice per group. Figure 2 . n = 8 for WT, n = 6 for Per1 KO. Significance was calculated by two-way ANOVA. *P < 0.01, **P < 0.001 compared to same genotype, w P < 0.05 compared to same time. compared to Per1 KO mice under control and HS/ DOCP conditions ( Figure S3 ). Thus, activity levels do not account for the higher MAP observed in Per1 KO mice.
Finally, in order to determine whether there was a change in the 24-h rhythm of BP, we subjected the hourly telemetry data to cosinor analysis. This allowed us to examine changes in circadian parameters that may have occurred in response to HS/DOCP and loss of PER1. Table 2 lists the values for amplitude (difference between the highest and lowest BP values), mesor (mean value for MAP across all time points), and phase (zeitgeber time at which MAP peaks) (Refinetti et al. 2007) . Consistent with our findings in Figure 3 , there was a significant change in mesor between WT (107.6 AE 5) and Per1 KO (121.2 AE 5.3) on HS/DOCP. Per1 KO mice on HS/ DOCP also had a significant phase shift (22.3 AE 1.3) compared to WT mice on HS/DOCP (19 AE 0.3, P = 0.018) as well as KO mice on control diet (18.2 AE 0.1, P = 0.013). Use of JTK cycle and cosinor analysis to evaluate circadian rhythms demonstrated significant rhythms in MAP (Tables S1 and S2) (P < 0.0001 for each mouse in every group).
Discussion
The most striking finding of this study was that loss of a single gene, Per1, in combination with high salt and mineralocorticoid treatment resulted in a non-dipping phenotype. Importantly, these significant results were observed in a relatively mild HS/DOCP model without surgical nephrectomy. This is also accompanied by a significant phase shift in the peak of MAP in Per1 KO compared to WT mice. To the best of our knowledge, this is the first demonstration of a nondipping, phase-shifted BP phenotype in a single clock gene KO mouse in response to a model of salt-sensitive hypertension.
We have previously demonstrated a role for PER1 in the regulation of renal sodium handling with accompanying effects on BP (Richards et al. 2013a ,b, 2014b , Solocinski et al. 2015 . The results of the present study further implicate PER1 as an important regulator of BP. When challenged with HS/DOCP, Per1 KO mice undergo increased BP as well as a disruption of the normal 24-h rhythm of BP. Our previous work in the hypertensive 129/sv mouse strain demonstrated a protective effect of Per1 KO on BP. This is not surprising given that strain-dependent differences in BP regulation are an established phenomenon, with wide-ranging baseline BP (Korshunov 2016) , sodium sensitivity Hartner et al. 2003 , (Cechova et al. 2013 ) and susceptibility to renal damage (Ma & Fogo 2003) and diabetic nephropathy (Brosius et al. 2009 ). Thus, the differences in baseline BP between Per1 KO mice on 129/sv and C57BL/6J backgrounds are likely due to strain-dependent differences in background genetics.
Even though non-dipping is a recognized problem with estimates of non-dipping prevalence as high as 45% (Viera et al. 2011) , the need for better treatments and thus better animal models remains. Other animal models of non-dipping hypertension have been identified using chronic models (Ivy et al. 2016) or ablation of multiple genes (Masuki et al. 2005 , Pati et al. 2016 . In-depth testing of Period isoform KOs in 129/sv mice by Rudic and colleagues further supports the importance of the PER proteins in blood pressure regulation (Pati et al. 2016) . In this study, angiotensin II infusion into Per2 KO mice in total darkness for 3 weeks elicited a non-dipping phenotype. Interestingly, a low salt diet resulted in non-dipping in Per1/2/3 KO mice in normal light conditions as well. It is difficult to directly compare these results due to the differences in background strain and treatment conditions. However, it is clear that the PER proteins are important regulators of BP. Thus, the The change in MAP from night to day is shown for wild-type (WT) mice and Per1 KO mice on control diet. (b) The change in MAP from night to day is shown for WT and Per1 KO mice on HS/DOCP diet for 6 days. Per cent dip is given for each group. Significance was calculated using a t-test. *P < 0.05. n = 8 for WT, n = 6 for Per1 KO.
novel model presented in this study is the first single gene knockout model to produce a hypertensive nondipping phenotype which develops quickly under normal light/dark conditions. In addition, WT C57Bl/6J mice are quite resistant to the current study regimen and usually require some additional insult to see a phenotype (Hartner et al. 2003 , Mohammed-Ali et al. 2015 , making the non-dipping exhibited by Per1 KO mice even more remarkable. Moreover, C57BL/6J Per1 KO mice are slightly hypertensive at baseline, which is a common characteristic of many non-dippers (Friedman & Logan 2009 , Cakici et al. 2014 . Non-dipping in humans can likely be attributed to many factors including kidney damage and salt-sensitive hypertension [reviewed in Birkenhager & van den Meiracker (2007) ]. The model presented here is pertinent to human disease as it has been demonstrated that high salt intake can blunt the nocturnal dip in humans (Higashi et al. 1997) and, conversely, restricted salt intake can help increase this dip (Uzu et al. 1997) . The changes observed in these mice likely involve the contribution of multiple organ systems since the current model is a global KO. It is evident that the vasculature and heart contribute to rhythms in cardiovascular function (reviewed in Martino & Young (2015) ) and the contribution of these systems to the regulation of BP rhythms is an active area of investigation. For example, Db/db mice displayed a non-dipping phenotype along with altered expression of clock gene mRNA levels in vascular smooth muscle tissue, which likely contributed to the non-dipping phenotype observed in this mouse model of diabetes (Su et al. 2012) . While the actions of PER1 in the vasculature remain largely unknown, the vasculature is an important mediator of BP regulation through changes in vessel compliance. Decreased compliance is accompanied by an increase in SBP and no change or a decrease in DBP (Gavish & Izzo 2016) . The parallel changes in DBP and SBP observed in these mice suggest a largely volume-dependent mechanism of hypertension which likely involves the action of the kidneys. Diuretics have been shown to reverse non-dipping in humans (Uzu & Kimura 1999) , suggesting a volume-dependent mechanism as well. The kidney is further implicated in the aetiology of non-dipping through the association of renal transplantation with an improvement in dipping status in humans (Gatzka et al. 1995) . While certain SNPs in Bmal1 have been associated with hypertension (Woon et al. 2007) , to the best of our knowledge there have been no studies large enough to identify SNPs in Per1 which could be attributed to salt sensitivity or non-dipping in humans. Taken together with the results of the present study, these findings support a role for the circadian clock and the kidney in the maintenance of baseline BP and rhythmic BP. In conclusion, Per1 KO C57BL/6J mice on HS/ DOCP regimen may represent an important new model for understanding mechanisms underlying non-dipping hypertension.
Limitations of this study include the fact that the mice used in this study are global KO. Thus, tissuespecific contributions to the non-dipping phenotype cannot be assessed. These studies were also limited to male mice. The experiments presented here were performed in a normal 12-h : 12-h light/dark cycle. Since a truly circadian process is defined as one that persists in the absence of light cues, determination of a true circadian defect would require the use of total darkness, an experimental manoeuver that is beyond the scope of the present report.
To place these findings in a clinical perspective, accumulating evidence suggests that chronotherapy, or dosing of medication at a specific time of day, can be helpful in treating non-dipping in certain patients (Portaluppi et al. 1995 , Hermida et al. 2008 . While chronotherapy or lifestyle changes can decrease nondipping prevalence in some patients, not all are helped by these interventions. Since non-dipping increases the risk of cardiovascular events, there is a need for better models and treatments. Our novel model of Per1 KO mice treated with a HS/DOCP regimen models a diminished dipping phenotype similar to that seen in humans and may provide a new way to test interventions. PER1 is again implicated in BP control and thus presents as a putative target for modulation of dipping status. The correlation between non-dipping and cardiovascular risk highlights not only the importance of normal circadian rhythms to overall health but also the way in which BP measurements are taken. 24-h ambulatory BP monitoring (ABPM) is a much more accurate predictor of dipping status and therefore future risk as it markedly reduces white-coat hypertension and placebo effects (Coats 1996 , Syrseloudis et al. 2011 , de la Sierra et al. 2012 . Somewhat similar to white-coat hypertension experienced by humans, mice can become stressed by tail-cuff BP measurements (Batchu et al. 2015 , Whitesall et al. 2004 . ABPM is a powerful method for BP studies since recordings are taken continuously as opposed to the snapshots generated from tail-cuff or office measurements.
In summary, here we present a new model of non-dipping hypertension: Per1 KO mice on a HS/ DOCP regimen. This is the first report of a single clock gene KO resulting in a non-dipping phenotype in response to high salt plus mineralocorticoid. The data implicate PER1 in the control of a normal dip in BP during the inactive period. This is especially significant given that C57BL/6J mice are often resistant to perturbations in BP. The new model of nondipping proposed here (Per1 KO mice on HS/DOCP) can also serve as a means of discovering new ways to treat non-dipping. In contrast to WT mice, global C57BL/6J Per1 KO mice are relatively hypertensive at baseline and are sensitive to a high salt/mineralocorticoid model of hypertension. These Per1 KO mice display attenuated dipping of BP which is similar to non-dipping hypertension in humans that is associated with increased risk of adverse cardiovascular events.
Sources of funding
The study was funded by NIH DK085193 and DK098460, ASN Foundation for Research to MLG and UF Hypertension Center NIH T32 HL083810 (K.S.) both diets. n = 8 for WT, n = 6 for Per1 KO. Figure S3 . WT and Per1 KO mice maintain inactive/active activity patterns on control and HS/DOCP diet. Activity patterns measured by telemetry were higher during the night than day in both genotypes on both control (a) and HS/DOCP (b) diets. Activity was significantly lower for Per1 KO on HS/DOCP compared to WT and thus does not account for the higher MAP observed. Statistics were calculated by two-way ANOVA. n = 8 for WT, n = 6 for Per1 KO. Table S1 . Analysis of MAP by JTK cycle. Table S2 . Analysis of MAP by cosinor analysis.
